O	0	11	Suppression	Suppression	NN	B-NP
O	12	14	of	of	IN	B-PP
B-Cancer	15	20	tumor	tumor	NN	B-NP
O	21	27	growth	growth	NN	I-NP
O	28	30	by	by	IN	B-PP
O	31	34	the	the	DT	B-NP
O	35	36	3	3	CD	I-NP
O	36	37	'	'	SYM	I-NP
O	38	50	untranslated	untranslated	JJ	I-NP
O	51	57	region	region	NN	I-NP
O	58	60	of	of	IN	B-PP
O	61	64	mel	mel	NN	B-NP
O	64	65	-	-	HYPH	B-NP
O	65	67	18	18	CD	I-NP
O	68	70	in	in	IN	B-PP
B-Cell	71	74	3Y1	3Y1	NN	B-NP
I-Cell	75	80	cells	cell	NNS	I-NP
O	81	92	transformed	transform	VBN	B-VP
O	93	95	by	by	IN	B-PP
O	96	99	the	the	DT	B-NP
O	100	102	E6	E6	NN	I-NP
O	103	106	and	and	CC	I-NP
O	107	109	E7	E7	NN	I-NP
O	110	115	genes	gene	NNS	I-NP
O	116	118	of	of	IN	B-PP
O	119	124	human	human	JJ	B-NP
O	125	139	papillomavirus	papillomavirus	NN	I-NP
O	140	144	type	type	NN	I-NP
O	145	147	18	18	CD	I-NP
O	147	148	.	.	.	O

O	150	152	By	By	IN	B-PP
O	153	164	introducing	introduce	VBG	B-VP
O	165	166	a	a	DT	B-NP
O	167	171	cDNA	cDNA	NN	I-NP
O	172	179	library	library	NN	I-NP
O	180	187	derived	derive	VBN	B-VP
O	188	192	from	from	IN	B-PP
O	193	196	rat	rat	NN	B-NP
B-Cell	197	206	embryonic	embryonic	JJ	I-NP
I-Cell	207	217	fibroblast	fibroblast	NN	I-NP
I-Cell	218	223	cells	cell	NNS	I-NP
O	223	224	,	,	,	O
O	225	227	we	we	PRP	B-NP
O	228	236	isolated	isolate	VBD	B-VP
O	237	244	several	several	JJ	B-NP
O	245	260	morphologically	morphologically	RB	I-NP
O	261	265	flat	flat	JJ	I-NP
B-Cell	266	276	revertants	revertant	NNS	I-NP
O	277	279	of	of	IN	B-PP
O	280	283	rat	rat	NN	B-NP
B-Cell	284	287	3Y1	3Y1	NN	I-NP
I-Cell	288	293	cells	cell	NNS	I-NP
O	294	305	transformed	transform	VBN	B-VP
O	306	308	by	by	IN	B-PP
O	309	312	the	the	DT	B-NP
O	313	315	E6	E6	NN	I-NP
O	316	319	and	and	CC	I-NP
O	320	322	E7	E7	NN	I-NP
O	323	328	genes	gene	NNS	I-NP
O	329	331	of	of	IN	B-PP
O	332	337	human	human	JJ	B-NP
O	338	352	papillomavirus	papillomavirus	NN	I-NP
O	353	357	type	type	NN	I-NP
O	358	360	18	18	CD	I-NP
O	361	362	(	(	(	O
O	362	367	HPV18	HPV18	NN	B-NP
O	367	368	)	)	)	O
O	368	369	.	.	.	O

O	370	374	From	From	IN	B-PP
O	375	378	one	one	CD	B-NP
O	379	381	of	of	IN	B-PP
O	382	385	the	the	DT	B-NP
B-Cell	386	396	revertants	revertant	NNS	I-NP
O	396	397	,	,	,	O
O	398	400	we	we	PRP	B-NP
O	401	410	recovered	recover	VBD	B-VP
O	411	412	a	a	DT	B-NP
O	413	414	0	0	CD	I-NP
O	414	415	.	.	.	I-NP
O	415	416	2	2	CD	I-NP
O	416	417	-	-	HYPH	I-NP
O	417	419	kb	kb	NN	I-NP
O	420	424	cDNA	cDNA	NN	I-NP
O	424	425	,	,	,	O
O	426	429	N56	N56	NN	B-NP
O	429	430	,	,	,	O
O	431	435	that	that	WDT	B-NP
O	436	446	suppresses	suppress	VBZ	B-VP
O	447	450	the	the	DT	B-NP
B-Cancer	451	456	tumor	tumor	NN	I-NP
O	457	463	growth	growth	NN	I-NP
O	464	466	of	of	IN	B-PP
O	467	470	the	the	DT	B-NP
B-Cell	471	482	transformed	transform	VBN	I-NP
I-Cell	483	486	3Y1	3Y1	NN	I-NP
I-Cell	487	492	cells	cell	NNS	I-NP
O	493	505	irrespective	irrespective	JJ	B-ADJP
O	506	508	of	of	IN	B-PP
O	509	512	the	the	DT	B-NP
O	513	523	expression	expression	NN	I-NP
O	524	526	of	of	IN	B-PP
O	527	530	the	the	DT	B-NP
O	531	533	E6	E6	NN	I-NP
O	534	537	and	and	CC	I-NP
O	538	540	E7	E7	NN	I-NP
O	541	546	genes	gene	NNS	I-NP
O	546	547	.	.	.	O

O	548	551	The	The	DT	B-NP
O	552	562	nucleotide	nucleotide	NN	I-NP
O	563	571	sequence	sequence	NN	I-NP
O	572	574	of	of	IN	B-PP
O	575	578	the	the	DT	B-NP
O	579	583	cDNA	cDNA	NN	I-NP
O	584	587	was	be	VBD	B-VP
O	588	593	shown	show	VBN	I-VP
O	594	596	to	to	TO	I-VP
O	597	599	be	be	VB	I-VP
O	600	609	identical	identical	JJ	B-ADJP
O	610	612	to	to	TO	B-PP
O	613	617	that	that	DT	B-NP
O	618	620	of	of	IN	B-PP
O	621	624	the	the	DT	B-NP
O	625	626	3	3	CD	I-NP
O	626	627	'	'	SYM	I-NP
O	628	640	untranslated	untranslated	JJ	I-NP
O	641	647	region	region	NN	I-NP
O	648	650	of	of	IN	B-PP
O	651	652	a	a	DT	B-NP
O	653	661	putative	putative	JJ	I-NP
O	662	671	mammalian	mammalian	JJ	I-NP
O	672	680	polycomb	polycomb	NN	I-NP
O	681	686	group	group	NN	I-NP
O	687	691	gene	gene	NN	I-NP
O	691	692	,	,	,	O
O	693	696	mel	mel	NN	B-NP
O	696	697	-	-	HYPH	O
O	697	699	18	18	CD	B-NP
O	699	700	.	.	.	O

